Name: Clinuvel Pharmaceuticals (CUV) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

CUV

Clinuvel Pharmaceuticals

Pharmaceuticals, Biotechnology & Life Sciences

Clinuvel Pharmaceuticals Ltd. is a pioneering Australian company specializing in the development of innovative treatments for UV and light-related skin disorders. Their flagship product, SCENESSE®, is the first systemic photoprotective drug approved for preventing phototoxicity in patients with erythropoietic protoporphyria. The company leverages its expertise in photomedicine and melanocortin peptides to address unmet medical needs globally.

Short position

short percentage8.32%

reported shorts4.2M

shares on issue50.428M

Clinuvel Pharmaceuticals (ASX:CUV) has 8.32% of its shares on issue reported as short positions as of 24 Aug 2026, or about 4,196,950 shares. Over the past 30 days that figure has fallen 0.54 percentage points, and over 90 days it has fallen 1.05 percentage points. Its highest recorded short interest was 9.59% in April 2020. CUV is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

CUV intelligence dossier

Public-source evidence for this company, with industry drill-up links.

Tax paid and taxable income records
Government contracts and public money
Emissions and trade exposure
Political donations and lobbying links

Short interest history & FAQ

CUV Short Interest History

30-day change: -0.54pp
90-day change: -1.05pp
1-year change: +1.35pp
All-time high: 9.59% (April 2020)
All-time low: 0.00% (November 2016)

Is CUV heavily shorted?

CUV's short interest of 8.31% is elevated relative to the ASX average, ranking #27 of 815 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.

How has CUV's short interest changed recently?

Over the past 30 days Clinuvel Pharmaceuticals's short interest has fallen 0.54 percentage points, and over 90 days it has fallen 1.05 percentage points. The current level is 8.31% of shares on issue.

What is the highest CUV's short interest has been?

Since 2010, Clinuvel Pharmaceuticals's short interest peaked at 9.59% in April 2020 and bottomed at 0.00% in November 2016.

Where does this data come from?

All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2010. See our methodology.